Recombinant Mycobacterium Tuberculosis Fusion Protein

Recombinant Mycobacterium Tuberculosis Fusion Protein

Products
Recombinant Mycobacterium Tuberculosis Fusion Protein
Recombinant Mycobacterium Tuberculosis Fusion Protein

Information

C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1?Suitable for Large Scale LTBI Screening? (2?Non Cross-React with BCG Vaccine; (3?WHO Guideline Recommended; (4) Easy Use, Low Cost;
Main Categories
Biopharmaceuticals
All Categories
BiopharmaceuticalsDiagnostics
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Chongqing Zhifei Biological Products Co.Ltd.Chongqing Zhifei Biological Products Co., Ltd. is the largest listed vaccine company in China?which has its presence in biological product industry in 2002.The Company achieved an operating income of RMB38.3 billion In 2022 with the support of its nearly 7000 employees.As a high-tech biological enterprise integrating the R&D, production, marketing, distribution as well as import & export, Zhifei mainly engages in the production of vaccines for human use. Our research channels cover many indications extensively: like COVID-19, tuberculosis, meningitis, etc.

Log in

See all the content and easy-to-use features by logging in or registering!